Feature Article

ipsita's picture

A mixed bag

Bigger cars buck improving trend The Pune based Automotive Research Association of India has shared random data cluster on fuel economy with the New Delhi based Centre for Science and

15
0
20070215
Publication Date: 
14/02/2007
Main Topic: 
ipsita's picture

What it takes

Fuel economy isn"t just good economics VERY crudely, the less fuel the vehicle consumes, the less it emits. Regulators across the world look at this problem in two waysÀ one, they directly

15
0
20070215
Publication Date: 
14/02/2007
thesaurus: 
Main Topic: 
ipsita's picture

What Europe did

Or not Europe shows how complex the diesel predicament can get if fuel economy regulations and local pollution abatement strategies are not equally stringent. The car industry in Europe agreed

15
0
20070215
Publication Date: 
14/02/2007
Main Topic: 
ipsita's picture

Take a bus

It really helps A 2006 Asian Development Bank study, Energy efficiency and climate change considerations for on-road transport in Asia, presents results from three case studies in South Asia

15
0
20070215
Publication Date: 
14/02/2007
thesaurus: 
Main Topic: 
ipsita's picture

Up to it, FM?

The memory of last year's oil price hike, and its economic and political fallouts, has faded from memory. As India awaits the 2007-08 Union budget, newspapers are abuzz with reports of more tax cuts

15
0
Publication Date: 
14/02/2007
20070215
Main Topic: 
susan's picture

Post-traumatic stress disorder in children and adolescents one year after a super-cyclone in Orissa, India: exploring cross-cultural validity and vulnerability factors

8
1-9
Publication Date: 
14/02/2007

It has been asserted that psychological responses to disasters in children and adolescents vary widely across cultures, but this has rarely been investigated. The objectives of the study were to clinically evaluate the construct of traumatic stress symptoms and disorder in children and adolescents after a super-cyclone in Orissa, India; to find out the prevalence at one year; compare the effect in high and low exposure areas and study the factors associated with it.

7
Main Topic: 
Name of the Journal: 
susan's picture

The forgotten issue of environmental crisis in Punjab elections

0
1
Publication Date: 
12/02/2007

It is election time in Punjab. Every body has started talking about development. The word Development has become a major issue. Election manifestos are painting a rosy picture of a Developed Punjab. But, none of them is kind enough to tell what will be cost of this development? And who has to bear the cost? Who will be sacrificed for this? More over how sustainable will be this development?

0
Main Topic: 
Author: 
Attachment(s): 
Name of the Journal: 
susan's picture

Biodiversity and indigenous knowledge system

3
275
Publication Date: 
10/02/2007

Biological diversity is an asset of vital significance to human beings, as it provides food, medicine and industrial raw materials along with an immense potential for accruing many unknown benefits to

92
Main Topic: 
Attachment(s): 
Name of the Journal: 
susan's picture

Epidemiological studies of pesticide exposed individuals and their clinical implications

3
340
Publication Date: 
10/02/2007

Epidemiological studies were conducted in pesticide exposed agricultural workers along with an equal number of age- and sex-matched controls. All the 200 exposed volunteers were suffering from fever, nausea, headache and other abnormal symptoms and visited the hospital for general health check-up. These cases

92
Name of the Journal: 
susan's picture

Taking TRIPS to India — Novartis, patent law, and access to medicines

6
541-543
Publication Date: 
08/02/2007

In August and September 2006, patients with cancer, lawyers for patient advocacy groups, and representatives of nongovernmental organizations (NGOs) converged on the offices of Novartis in Mumbai, India, to protest the company's efforts to obtain an Indian patent on Gleevec, the company's brand-name version of imatinib mesylate. Gleevec (spelled Glivec outside the United States) is used to treat chronic myeloid leukemia, and Novartis has patented the drug in 35 countries.

356
Main Topic: 
Attachment(s): 
Name of the Journal: 

Pages